Study in Patients With Asthma

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

• Patients with a history of asthma

Exclusion Criteria:

• Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization

• History of smoking

• Debilitating systemic and/or life-threatening diseases.